Safety and efficacy of combined antiplatelet and low-dose rivaroxaban in patients with chronic limb threatening ischaemia in Singapore
Author:
Affiliation:
1. National University Hospital, Singapore
2. The Vascular & Endovascular Clinic, Gleneagles Medical Centre, Singapore
3. Singapore General Hospital, Singapore
Publisher
Academy of Medicine, Singapore
Subject
General Medicine
Reference9 articles.
1. Ang Y, Yap CW, Saxena N, et al. Diabetes-related lower extremity amputations in Singapore. Proc Singapore Healthc 2017;26:76-80.
2. Ying AF, Tang TY, Jin A, et al. Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study. Cardiovasc Diabetol 2022;21:7.
3. Soon SXY, Patel A, Chong TT, et al. Distribution of Peripheral Arterial Disease in Patients Undergoing Endovascular Revascularization for Chronic Limb Threatening Ischaemia: Insights from the Vascular Quality Initiative in Singapore. Vasc Specialist Int 2021;37:13.
4. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017;377:1319-30.
5. Debus ES, Nehler MR. The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients. Eur J Vasc Endovasc Surg 2020;59:699-700.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3